Any thoughts on the strategic priorities for this and next year? I like that there is major movement on several candidates, with some entering late-stage trials as soon as this summer. I don't see much talk about this stock, but I have been keeping my eye on it and I think we could see a breakthrough soon enough.
There are no replies in this thread yet. Be the first to post a reply below: